Literature DB >> 22299410

Hepatitis B among pregnant women attending health care facilities in rural Bangladesh.

Md Shamsuzzaman1, P Singhasivanon, J Kaewkungwal, S Lawpoolsri, P Tangkijvanich, Robert V Gibbons, M Rahman, A S M Alamgir, M A Mahtab.   

Abstract

This study assessed hepatitis B prevalence among pregnant women attending health care facilities in rural Bangladesh. Blood samples were collected from 480 participants. HBsAg was positive in 0.4% of subjects, anti-HBc was positive in 21.5% and anti-HBs was positive in 8.5% of subjects. HBsAg was more prevalent among the older age group. Hepatitis B has a low prevalence among pregnant women in rural Bangladesh. Existing hepatitis B vaccination schedule in the Expanded Program on Immunization (EPI) to vaccinate the children in rural Bangladesh is appropriate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22299410

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

Review 1.  Epidemiology of Hepatitis B Virus Infection in Bangladesh: Prevalence among General Population, Risk Groups and Genotype Distribution.

Authors:  Md Hassan Uz-Zaman; Ayesha Rahman; Mahmuda Yasmin
Journal:  Genes (Basel)       Date:  2018-11-08       Impact factor: 4.096

2.  Antihepatitis B Surface Antigen and Hepatitis C Antibodies among Pregnant Women in an Urban Area of Mwanza City, Tanzania.

Authors:  Elieza Chibwe; Vitus Silago; Edwin Kajoro; Muhsin Juma; Emmanuel Mkumbo; Caroline A Minja; Fridolin Mujuni; Stephen E Mshana; Mariam M Mirambo
Journal:  J Pregnancy       Date:  2019-06-18

3.  Co-infection and Risk Factors Associated with STIs among Pregnant Women in Rural Health Facilities in Nigeria: A Retrospective Study.

Authors:  MaryJoy Umoke; Peter Sage; Tor Bjoernsen; Prince Christian Ifeanachor Umoke; Christian Ezeugworie; Daniel Ejiofor; Ogbonna Agha; Chioma Adaora Nwalieji; Rosemary N Onwe; Ifeanyi Emmanuel Nwafor; Obinna Jude Chukwu
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.